Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
. 2020 Dec:79:153333.
doi: 10.1016/j.phymed.2020.153333. Epub 2020 Sep 2.

Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of 2019-nCoV Spike pseudotyped virus

Affiliations

Chloroquine and hydroxychloroquine as ACE2 blockers to inhibit viropexis of 2019-nCoV Spike pseudotyped virus

Nan Wang et al. Phytomedicine. 2020 Dec.

Abstract

Background: The novel coronavirus disease (2019-nCoV) has been affecting global health since the end of 2019 and there is no sign that the epidemic is abating . The major issue for controlling the infectious is lacking efficient prevention and therapeutic approaches. Chloroquine (CQ) and Hydroxychloroquine (HCQ) have been reported to treat the disease, but the underlying mechanism remains controversial.

Purpose: The objective of this study is to investigate whether CQ and HCQ could be ACE2 blockers and used to inhibit 2019-nCoV virus infection.

Methods: In our study, we used CCK-8 staining, flow cytometry and immunofluorescent staining to evaluate the toxicity and autophagy of CQ and HCQ, respectively, on ACE2 high-expressing HEK293T cells (ACE2h cells). We further analyzed the binding character of CQ and HCQ to ACE2 by molecular docking and surface plasmon resonance (SPR) assays, 2019-nCoV spike pseudotyped virus was also used to observe the viropexis effect of CQ and HCQ in ACE2h cells.

Results: Results showed that HCQ is slightly more toxic to ACE2h cells than CQ. Both CQ and HCQ could bind to ACE2 with KD = (7.31 ± 0.62)e-7 M and (4.82 ± 0.87)e-7 M, respectively. They exhibit equivalent suppression effect for the entrance of 2019-nCoV spike pseudotyped virus into ACE2h cells.

Conclusions: CQ and HCQ both inhibit the entrance 2019-nCoV into cells by blocking the binding of the virus with ACE2. Our findings provide novel insights into the molecular mechanism of CQ and HCQ treatment effect on virus infection.

Keywords: 2019-nCoV; ACE2; Chloroquine; Hydroxychloroquine.

PubMed Disclaimer

Conflict of interest statement

The authors declare no competing financial interest.

Figures

Fig. 1
Fig. 1
Effect of CQ and HCQ on the viability of ACE2h cells. A. Western blotting analysis of the expression levels of ACE2 protein in EOL-1 cells, AT2 cells, HSAEpC cells, and ACE2h cells. B. Viability of ACE2h cells treated with CQ or HCQ for 24 h. C. The toxicity of HCQ and CQ on ACE2h cells at different time points. D. Calcium (Ca2+) flux change in ACE2h cells. E. The apoptosis of ACE2h cells treated with CQ or HCQ for 24 h. The experiments were repeat three times. Data are presented as mean ± S.D. (* p < 0.05, ** p < 0.01, ***p < 0.001, compared with HEK293T, or concentration was 0, or HCQ 20 μM, #p < 0.05 compared with HCQ 10 μM at corresponding time points).
Fig. 2
Fig. 2
Effects of CQ and HCQ on the LC3 levels of ACE2h cells. ACEh cells were treated with different doses of CQ or HCQ for 24 h. (A) Effects of CQ and HCQ on the fluorescent staining of FITC-LC3 and TRITC-Phalloidin in ACEh cells. (B) The representative blots of autophagy proteins and changes of LC3-II/LC3-I ratio. The experiments were repeat three times. Data are presented as mean ± S.D. * p < 0.05, ** p < 0.01, *** p < 0.001 compared with control.
Fig. 3
Fig. 3
Binding character of CQ and HCQ with ACE2. A. Structural formulas of CQ and HCQ. B. SPR analysis of CQ or HCQ and ACE2. C. Molecular docking of CQ and HCQ with ACE2.
Fig. 4
Fig. 4
Effect of CQ and HCQ on the entrance of 2019-nCoV spike pseudotyped virus into ACE2h cells. The experiments were repeat three times. Data are presented as mean ± S.D. * p < 0.05, ** p < 0.01, *** p < 0.001 compared with group 0.

References

    1. Abdelli I., Hassani F., Brikci S.B., Ghalem S. In silico study the inhibition of angiotensin converting enzyme 2 receptor of COVID-19 by ammoides verticillata components harvested from Western Algeria. J. Biomol. Struct. Dyn. 2020 - PMC - PubMed
    1. Al-Bari M.A.A. Targeting endosomal acidification by chloroquine analogs as a promising strategy for the treatment of emerging viral diseases. Pharmacol. Res. Perspe. 2017;5 - PMC - PubMed
    1. Brufsky A. Hyperglycemia, hydroxychloroquine, and the COVID-19 pandemic. J. Med. Virol. 2020;92:770–775. - PMC - PubMed
    1. Delvecchio R., Higa L.M., Pezzuto P., Valadao A.L., Garcez P.P., Monteiro F.L., Loiola E.C., Dias A.A., Silva F.J., Aliota M.T., Caine E.A., Osorio J.E., Bellio M., O’Connor D.H., Rehen S., de Aguiar R.S., Savarino A., Campanati L., Tanuri A. Chloroquine, an endocytosis blocking agent, inhibits zika virus infection in different cell models. Viruses. 2016;8 - PMC - PubMed
    1. Fantini J., Di Scala C., Chahinian H., Yahi N. Structural and molecular modelling studies reveal a new mechanism of action of chloroquine and hydroxychloroquine against SARS-CoV-2 infection. Int. J. Antimicrob. Agents. 2020;55 - PMC - PubMed

LinkOut - more resources